Why the study?
What are the long-term outcomes and residual abnormalities in patients operated upon for coarctation of the aorta?
What are the long-term outcomes and residual abnormalities in patients operated upon for coarctation of the aorta?
Patients who undergo surgical correction for coarctation of the aorta require lifelong follow-up due to a high prevalence of associated anomalies, residual hemodynamic abnormalities, and late cardiovascular events.
May support lifelong surveillance after coarctation repair; extends observational data on late mortality and residual LVH.
One hundred and ninety patients over the age of two operated upon for coarctation of the aorta from 1957 to 1972 at one institution were followed for one to 15.5 years (mean, 6.6 years). There were eleven cardiovascular deaths in the follow-up period. The mean age at death was 32.5 years. Two-thirds of the patients had an associated cardiovascular anomaly; 74 had coexistent aortic valve disease, and 19 had mitral stenosis or insufficiency. Five patients had a significant central nervous system event in the late postoperative period. Left ventricular hypertrophy by electrocardiogram was noted in 45, and 72 had radiographic left ventricular hypertrophy. A significant persistent or residual hemodynamic abnormality, either congenital heart disease, residual coarctation or persistent diastolic hypertension, could account for the residual electrocardiographic or radiographic abnormality. The data indicate that this population requires continuing care despite correction of the coarctation.
No takes yet. Share an insight, caveat, or question.
Simón et al. (1974) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: